And this is where its important to state that we cant really yet know exactly what the side effect profile is going to be because until this is used by populations at large we can only really extrapolate our expectations, made from mechanistic understanding and some of what was picked up in those trials
I have had some positive results and remain determined to continue with my healthier progress going forward
Some of the respondents of these surveys also indicated having experience with, but were no longer taking, the following medications: sulfonylureas, GLP-1 receptor agonists, DPP-4 inhibitor, DPP-4 plus metformin, meglitinides, SGLT2 inhibitors, short-acting insulin, premixed insulin, U300/other long-acting insulin, orlistat and metformin
Buteau J, Roduit R, Susini S, Prentki M
Can I split Rybelsus tablets to make them last longer